J1I-MC-GZBB - ClinicalTrials.gov - NCT04143802
J1I-MC-GZBB - ClinicalTrials.gov - NCT04143802
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must be diagnosed with type 2 diabetes for at least six months
Participants must have stable body weight for the last 3 months
Participants must be overweight or very overweight - Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant
Participants must NOT
Participants must not have known complication of diabetes
Participants must not have Type 1 diabetes mellitus
Participants must not have uncontrolled diabetes, (meaning that they required hospitalization for treatment of life-threatening complications of diabetes in the last six months)
Participants must not have had severe low blood sugar requiring emergency treatment
Participants must not have inflammation of the pancreas
Participants must not have known liver disease
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY3437943, Dulaglutide, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
75
Trial Dates
December 2019 - December 2020
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must be diagnosed with type 2 diabetes for at least six months
Participants must have stable body weight for the last 3 months
Participants must be overweight or very overweight - Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant
Participants must NOT
Participants must not have known complication of diabetes
Participants must not have Type 1 diabetes mellitus
Participants must not have uncontrolled diabetes, (meaning that they required hospitalization for treatment of life-threatening complications of diabetes in the last six months)
Participants must not have had severe low blood sugar requiring emergency treatment
Participants must not have inflammation of the pancreas
Participants must not have known liver disease
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY3437943, Dulaglutide, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
75
Trial Dates
December 2019 - December 2020
Trial Phase
1
Trial Locations
Hide locations not currently recruiting